Medicine and Dentistry
Transitional Cell Carcinoma
66%
Cystectomy
38%
Quality of Life
37%
Metastatic Carcinoma
35%
Gemcitabine
33%
Cisplatin
33%
Ileal Conduit
33%
Brachytherapy
33%
Bladder Cancer
33%
Prostate Specific Antigen
33%
Neurogenic Tumor
33%
Pembrolizumab
33%
Elderly Patient
33%
Prostate Cancer
33%
Iodine 125
33%
Clear Cell Renal Cell Carcinoma
33%
Bladder
33%
Urinary System
33%
Neoplasm
33%
Paclitaxel
33%
Kidney Autotransplantation
33%
Histology
33%
Kidney Cancer
33%
Cardiovascular System
33%
Radical Nephrectomy
33%
Propensity Score Matching
33%
Partial Nephrectomy
28%
Urinary Diversion
27%
Systemic Therapy
20%
Stereotactic Body Radiation Therapy
20%
Immune Checkpoint Inhibitor
13%
Kidney Metastasis
13%
Malignant Neoplasm
13%
Combination Therapy
12%
Group Therapy
11%
Orgasm
11%
Indigo Carmine
11%
Vaginal Wall
11%
Overall Survival
11%
Micturition
11%
Secretion (Process)
11%
Primary Tumor
10%
Surgery
10%
Progression Free Survival
9%
Ganglioneuroma
8%
Functional Imaging
8%
Tumor Microenvironment
6%
Metastasectomy
6%
Radiation Therapy
6%
Antacid
6%
Pharmacology, Toxicology and Pharmaceutical Science
Transitional Cell Carcinoma
100%
Pembrolizumab
66%
Renal Cell Carcinoma
46%
Metastasis
44%
Overall Survival
41%
Neoplasm
33%
Gemcitabine
33%
Adenoviridae
33%
Tumor Growth
33%
Kidney Cancer
33%
Adverse Event
33%
Bladder Cancer
33%
Cisplatin
33%
Prostate Cancer
33%
Cancer Model
33%
Paclitaxel
33%
Chemotherapy
33%
Antacid Agent
33%
Endocrine Therapy
33%
Proton Pump Inhibitor
33%
Cefditoren Pivoxil
33%
Malignant Neoplasm
32%
Immune Checkpoint Inhibitor
25%
Histamine H2 Receptor Antagonist
23%
Kidney Metastasis
22%
Progression Free Survival
19%
Mouse
16%
Primary Tumor
15%
Combination Therapy
11%
Clinical Trial
11%
Disease
11%
Recurrent Disease
11%
Tumor Microenvironment
11%
Cancer Specific Survival
10%
Side Effect
8%
Metalloproteinase
8%
Tumor Suppressor Protein
8%
Triacylglycerol
8%
Creatinine
8%
Adenovirus Vector
8%
Therapeutic Effect
8%
Cancer Growth
8%
Polycythemia vera
8%
Dyslipidemia
8%
Gene Delivery
8%
Uric Acid
8%
Lymph Node Metastasis
8%
Combination Drug
6%
Pneumonia
6%
Neutropenia
5%
Keyphrases
Muscular Development
33%
Trans Men
33%
Body Composition Changes
33%
Ureterocutaneostomy
33%
Heat Shock Proteins
33%
Sexual Stimulation
33%
Baseline Tumor Size
33%
Neurogenic Tumor
33%
Urinary Bladder Cancer
33%
Heat Shock Protein 70 (HSP70)
33%
Bladder Tuberculosis
33%
Advanced Renal Cancer
33%
Tumor-specific
33%
Dickkopf-3
33%
Apoptosis
33%
Gemcitabine Chemotherapy
33%
Cefditoren pivoxil
33%
Propensity Score Analysis
33%
Renal Cell Carcinoma
33%
Robot-assisted Partial Nephrectomy
33%
Percutaneous Cryoablation
33%
Partial Images
33%
Image-guided
33%
Small Renal Cancer
33%
Adenovirus
20%
Renca
20%
Large Baseline
14%
Microbiological Efficacy
14%
C-Jun N-terminal Kinase
13%
DKK3
13%
Tumor Cells
13%
Induced Apoptosis
13%
NIH3T3
13%
Apoptosis Induction
13%
Radiological Response
13%
Menstrual Cessation
11%
Clinical T1
9%
Oncological Outcomes
9%
Sex Work
8%
Female Prostate
8%
Skene's Glands
8%
Ganglioneuroma
8%
Two-kidney
8%
Functional Imaging
8%
Bcl-2 Inhibitor
8%
ER Stress Response
8%
Oligoprogression
8%
Recurrent Renal Cell Carcinoma
8%
Intervention Modalities
8%
Family Work
8%